Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05399290 · ClinicalTrials.gov registry record · Phase 4
Subantimicrobial Doxycycline in Acne
A Phase 4 study, sponsored by Michigan State University.
- Completed
- Registry status
- Phase 4
- Development phase
- 22
- Enrollment target
NCT05399290 is a Phase 4 study that has completed, run by Michigan State University. The registered enrollment target is 22 participants.
The verdict
NCT05399290, a Phase 4 study, has completed, sponsored by Michigan State University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 22 participants
- Enrollment target
Study Summary
Antibiotic resistance is a public health problem that worsens the more physicians prescribe standard dose antibiotics for acne. Regardless of race, acne vulgaris is one of the most common dermatologic conditions among pediatric populations. As such, clinicians can make a large impact by practicing good antibiotic stewardship while still addressing the impact of acne on adolescents' self-esteem. Subantimicrobial doxycycline maintains its anti-inflammatory effects while eliminating antimicrobial properties and associated risks of drug resistance. Few studies, focused primarily on adults, have shown that subantimicrobial doxycycline is efficacious in treating acne from a physician standpoint. The investigators aim to investigate the patient experience of acne treatment with subantimicrobial dose doxycycline in the pediatric population.
Interventions
- DRUG Doxycycline Hyclate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2020-11-19 |
| Est. Completion | 2021-11-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05399290
The ClinicalTrials.gov registry entry for NCT05399290 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Michigan State University, which has 120 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Doxycycline Hyclate is the first listed.
NCT05399290 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05399290 about?
NCT05399290 is a clinical study titled "Subantimicrobial Doxycycline in Acne". Antibiotic resistance is a public health problem that worsens the more physicians prescribe standard dose antibiotics for acne. Regardless of race, acne vulgaris is one of the most common dermatologic conditions among pediatric populations. As such, clinicians can make a large impact by practicing g...
What is the current status of trial NCT05399290?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 22 participants. The study started on 2020-11-19. Estimated completion is 2021-11-08.
What interventions are being tested in trial NCT05399290?
The interventions under investigation include: Doxycycline Hyclate (DRUG).
Who is sponsoring clinical trial NCT05399290?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.